TUMOUR INFLAMMATION-ASSOCIATED NEUROTOXICITY

TUMOUR INFLAMMATION-ASSOCIATED NEUROTOXICITY was reported 7 times

TUMOUR INFLAMMATION-ASSOCIATED NEUROTOXICITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD19-directed Chimeric Antigen Receptor [EPC] 2 0.0002
1 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Platinum-based Drug [EPC] 1 0.0000
4 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 3 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000